This is the authors' abstract. We don't add key points for this paper.
An Et 3 N-catalyzed cascade [3 + 2]-annulation of β-oxo-acrylamides with cyclic N -sulfonyl ketimines or sulfamate-derived imines is developed under mild reaction conditions, which provides a concise and efficient route to access valuable sultam- or sulfamidate-fused imidazolidinone derivatives in good to excellent yields (80–95% yields) with excellent diastereoselectivities (>20:1 drs). The current protocol features atom economy, a transition-metal-free process, and broad functional group tolerance. Moreover, the asymmetric variant of the [3 + 2]-cycloaddition reaction was achieved in the presence of diphenylethanediamine or quinine-based bifunctional squaramide organocatalysts C-1 and C-11, giving the corresponding chiral polycyclic imidazolidinones in 68–90% yields with 25–94% ees and >20:1 drs in all cases.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: